Purpose This study aimed to evaluate the molecular features of clear cell adenocarcinoma (CCA) of the urinary tract and investigate its pathogenic pathways and possible actionable targets.
Materials and Methods We retrospectively collected the data of patients with CCA between January 1999 and December 2016; the data were independently reviewed by two pathologists. We selected five cases of urinary CCA, based on the clinicopathological features. We analyzed these five cases by whole exome sequencing (WES) and subsequent bioinformatics analyses to determine the mutational spectrum and possible pathogenic pathways.
Results All patients were female with a median age of 62 years. All tumors were located in the urethra and showed aggressive behavior with disease progression. WES revealed several genetic alterations, including driver gene mutations (AMER1, ARID1A, CHD4, KMT2D, KRAS, PBRM1, and PIK3R1) and mutations in other important genes with tumor-suppressive and oncogenic roles (CSMD3, KEAP1, SMARCA4, and CACNA1D). We suggest putative pathogenic pathways (chromatin remodeling pathway, mitogen-activated protein kinase signaling pathway, phosphoinositide 3-kinase/AKT/mammalian target of rapamycin pathway, and Wnt/β-catenin pathway) as candidates for targeted therapies.
Conclusion Our findings shed light on the molecular background of this extremely rare tumor with poor prognosis and can help improve treatment options.
Citations
Citations to this article as recorded by
Urethral clear cell adenocarcinoma in an adult female: A rare case report Yacob Sheiferawe Seman, Michael Teklehaimanot Abera, Fadil Nuredin Abrar, Tesfaye Kebede Legesse, Mesfin Asefa Tola, Tsiyon Nigusie Alemu Urology Case Reports.2025; 58: 102882. CrossRef
Two rare cases of primary clear cell adenocarcinoma of the urethra: clinical experience, case report and literature review Bohao Jiang, Jiyuan Hu, Benqiao Wang, Xujia Liu, Ling Tong, Yitong Xu, Hao Zhang Frontiers in Oncology.2025;[Epub] CrossRef
Association between CACNA1D polymorphisms and hypospadias in a southern Chinese population Ye He, Binyao Li, Xinying Zhao, Lingling Pan, Yanqing Liu, Chaoting Lan, Fuming Deng, Wen Fu, Yan Zhang, Xiaoyu Zuo Journal of Pediatric Urology.2024; 20(3): 438.e1. CrossRef
The L‐type calcium channel CaV1.3: A potential target for cancer therapy Xuerun Liu, Boqiang Shen, Jingyi Zhou, Juan Hao, Jianliu Wang Journal of Cellular and Molecular Medicine.2024;[Epub] CrossRef
Purpose
Angiosarcoma is a highly aggressive mesenchymal tumor. Although systemic chemotherapy is often considered for the inoperable or metastatic angiosarcoma, the outcome of such treatment is unsatisfactory and poorly delineated.
Materials and Methods
We reviewed electronic medical records of 75 patients with angiosarcoma who were treated with systemic chemotherapy for inoperable or metastatic disease. Patients were classified as having liver involvement if they had either primary or metastatic hepatic lesions.
Results
Among the patients evaluated, 51 patients were male (68%) and 24 patients (32%) had primary cutaneous angiosarcoma. Liver involvement was present in 28 patients (37.3%). A total of 59 patients received first-line weekly paclitaxel (wPac) and showed an objective response rate (ORR) of 23.7% (n=14), a median progression free survival (mPFS) of 4.0 months (95% confidence interval [CI] 3.0–6.1), and a median overall survival (mOS) of 10.2 months (95% CI 7.0–14.6). Among patients without liver involvement, patients receiving wPac (n=35) had significantly prolonged mPFS (5.8 vs. 3.2 months, respectively, p=0.014) with a tendency for prolonged mOS (13.8 vs. 11.6 months, respectively, p=0.13) than those receiving other regimens (n=12). A total of 24 patients received second- or later-line pazopanib monotherapy and showed an ORR of 16.7% (n=4), a mPFS of 2.4 months (95% CI 1.8–4.3) and a mOS of 5.4 months (95% CI 3.5–NA).
Conclusion
Treatment with first-line wPac and later-line pazopanib seems to provide survival benefit, especially for patients with advanced angiosarcoma without liver involvement.
Citations
Citations to this article as recorded by
Punch Biopsy as a Diagnostic Keystone for Metastatic Cardiac Angiosarcoma Treated With Anthracycline-Based Chemotherapy: A Case Report Aonghus Joyce, Gráinne Murphy, Cynthia C Heffron, David Aherne, Richard M Bambury Cureus.2025;[Epub] CrossRef
Clinicopathological features, treatment outcomes, and prognostic factors of angiosarcoma: a 21-year experience at one center Chenyan Fang, Xiaoting Zeng, Qing Ji, Tao Zhu, Meiyu Fang, Jun Cao Orphanet Journal of Rare Diseases.2025;[Epub] CrossRef
Chest Wall Angiosarcoma with an Initial Presentation of Multiple Lung Metastases: a Case Report Hitoshi Suzuki, Mari Shinoda, Daisuke Ito, Shin Shomura, Kentaro Inoue, Kazuo Fukutome, Akira Shimamoto, Hisamichi Yuda Haigan.2024; 64(7): 917. CrossRef
Conversion surgery for recurrent hepatic angiosarcoma after systemic chemotherapy with paclitaxel Yuta Ushida, Takafumi Sato, Tomotaka Kato, Yasuyuki Shigematsu, Hiromichi Ito, Takeshi Suzuki, Yosuke Inoue, Yoshihiro Ono, Atsushi Oba, Yu Takahashi Clinical Journal of Gastroenterology.2022; 15(2): 427. CrossRef
Management of Cutaneous Angiosarcoma: an Update Review Siwei Bi, Ai Zhong, Xiya Yin, Jingyi Li, Ying Cen, Junjie Chen Current Treatment Options in Oncology.2022; 23(2): 137. CrossRef
Results of NC-6300 (Nanoparticle Epirubicin) in an Expansion Cohort of Patients with Angiosarcoma Richard F Riedel, Victoria Chua, Ania Moradkhani, Natalie Krkyan, Amir Ahari, Atsushi Osada, Sant P Chawla The Oncologist.2022; 27(10): 809. CrossRef
Purpose The purpose of this study is to report on the incidence and the experience in management of radiation-induced sarcoma (RIS) at a large single center in Korea for 15 years.
Materials and Methods We retrospectively reviewed the sarcoma registry of a large institution from January 2000 to April 2014.
Results Out of the 3,674 patients listed in the registry, 33 patients (0.9%) diagnosed with RIS were identified. The median latency of RIS was 12.1 years. The number of cases of RIS increased from four cases in the years 2000-2003 to 14 cases in the years 2012-2014. The most common histology was osteosarcoma (36.4%). The median follow-up period was 23.1 months, the median overall survival (OS) of all patients was 2.9 years, and their 5-year survival rate was 44.7%. Univariate and multivariate analyses showed association of the age at diagnosis (p=0.01) and the treatment aim (p=0.001) with the OS. The median OS and the 5-year survival rate of patients treated with curative surgery (n=19) were 9.6 years and 65%, respectively, and of the conservatively treated patients, 0.7 years and 0% (n=14). Re-irradiation was delivered to nine patients, and radiation toxicity was observed in five patients.
Conclusion In this study, RIS accounted for 0.9% of the cases of sarcoma, with increasing incidence. Despite the association of curative resection with increased survival, it could be applied to only 58% of the patients. Considering the limited treatment options for RIS, conduct of a genetic study to identify the underlying mechanism of RIS is needed.
Citations
Citations to this article as recorded by
Radiation-induced osteosarcoma in the head and neck region: Case report and literature review Iara Vieira Ferreira, Marcelo Elias Schempf Cattan, Carlos Takahiro Chone, Arthur Antolini, Erika Said Abu Egal, Albina Altemani, Fernanda Viviane Mariano Oral Oncology.2025; 162: 107216. CrossRef
A bone tumor‐like chest wall mass lesion with pathological rib fractures observed 13 years after lung stereotactic body radiotherapy: A case report Masaki Matsuda, Jiro Ichikawa, Takafumi Komiyama, Kojiro Onohara, Masahide Saito, Hikaru Nemoto, Mizuki Kubota, Hiroshi Onishi Thoracic Cancer.2024; 15(26): 1912. CrossRef
The role of perioperative treatment in radiation-associated soft tissue sarcomas Konrad Zasadziński, Mateusz Jacek Spałek Oncologie.2024; 26(6): 1065. CrossRef
Clinical and Pathologic Characterization of 94 Radiation-Associated Sarcomas: Our Institutional Experience Erica Y. Kao, Abbye E. McEwen, James K. Aden, Stephanie K. Schaub, Robert W. Ricciotti, Jose G. Mantilla International Journal of Surgical Pathology.2023; 31(5): 532. CrossRef
Clinico-demographic characteristics and outcomes of radiation-induced sarcomas (RIS): a CanSaRCC study Mauricio Fernando Ribeiro, Hagit Peretz Soroka, Zainab Bhura, Ian Hirsch, Jay Wunder, Peter Ferguson, Kim Tsoi, Savtaj Brar, Rebecca Gladdy, Carol Swallow, Peter Chung, Charles Catton, Philip Wong, Geoffrey Watson, Albiruni Ryan Abdul Razak, Abha A. Gupta Therapeutic Advances in Medical Oncology.2023;[Epub] CrossRef
Treatment and Outcomes of Radiation-Induced Soft Tissue Sarcomas of the Extremities and Trunk—A Systematic Review of the Literature Maria L. Inchaustegui, Kelly Kon-Liao, Kim Ruiz-Arellanos, George Aquilino E. Silva, Marcos R. Gonzalez, Juan Pretell-Mazzini Cancers.2023; 15(23): 5584. CrossRef
Temporary Knockdown of p53 During Focal Limb Irradiation Increases the Development of Sarcomas Andrea R. Daniel, Chang Su, Nerissa T. Williams, Zhiguo Li, Jianguo Huang, Omar Lopez, Lixia Luo, Yan Ma, Lorraine da Silva Campos, Sara R. Selitsky, Jennifer L. Modliszewski, Siyao Liu, Rosa Hernansaiz-Ballesteros, Yvonne M. Mowery, Diana M. Cardona, Cha Cancer Research Communications.2023; 3(12): 2455. CrossRef
Treatment related factors associated with the risk of breast radio-induced-sarcoma Céline Mirjolet, Ibrahima Diallo, Aurélie Bertaut, Cristina Veres, Paul Sargos, Sylvie Helfre, Marie-Pierre Sunyach, Gilles Truc, Cécile Le Pechoux, Amaury Paumier, Anne Ducassou, Maria Jolnerovski, Juliette Thariat, Michel Lapeyre, Abel Cordoba, Marc-And Radiotherapy and Oncology.2022; 171: 14. CrossRef
Radiation-induced osteosarcoma in the pubic bone after proton radiotherapy for prostate cancer: a case report Hiroatsu Nakashima, Tetsuro Takatsu, Reiko Imai Journal of Rural Medicine.2022; 17(2): 94. CrossRef
Premalignant Conditions of Bone Michael D. Eckhoff, Matthew E. Wells, Osvaldo Padilla, Elizabeth M. Polfer, Christopher J. Castagno, Ahmed M. Thabet, Shaimaa Elzamly, Harry L. Wilson, Rajiv Rajani JAAOS: Global Research and Reviews.2022;[Epub] CrossRef
Histology-Specific Prognostication for Radiation-Associated Soft Tissue Sarcoma Edmund K. Bartlett, Avinash Sharma, Kenneth Seier, Cristina R. Antonescu, Narasimhan P. Agaram, Bhumika Jadeja, Evan Rosenbaum, Ping Chi, Murray F. Brennan, Li-Xuan Qin, Kaled M. Alektiar, Samuel Singer JCO Precision Oncology.2022;[Epub] CrossRef
Radiation-induced soft tissue sarcoma of the neck after radiation therapy for Hodgkin's lymphoma: a clinical case Nikolai A. Ognerubov, Tatiana S. Antipova Journal of Modern Oncology.2022; 24(3): 325. CrossRef
Prognostic Score-Based Stratification Analysis Reveals Universal Benefits of Radiotherapy on Lowering the Risk of Ipsilateral Breast Event for Ductal Carcinoma In Situ Patients with Different Risk Levels Libo Yang, Dongli Lu, Yutian Lai, Mengjia Shen, Qiuxiao Yu, Ting Lei, Tianjie Pu, Hong Bu Annals of Surgical Oncology.2021; 28(2): 975. CrossRef
Radiation-Induced Sarcomas of the Head and Neck: A Systematic Review Andrés Coca-Pelaz, Antti A. Mäkitie, Primož Strojan, June Corry, Avraham Eisbruch, Jonathan J. Beitler, Sandra Nuyts, Robert Smee, Johannes A. Langendijk, William M. Mendenhall, Cesare Piazza, Alessandra Rinaldo, Alfio Ferlito Advances in Therapy.2021; 38(1): 90. CrossRef
En bloc resection and reconstruction in patients with advanced recurrent nasopharyngeal carcinoma and radiation-induced sarcoma of the head and neck W.-l. Chen, Y.-M. Liu, B. Zhou, R. Chen, Z.-y. Lin, Z.-q. Huang, Z-x. Huang International Journal of Oral and Maxillofacial Surgery.2021; 50(6): 711. CrossRef
Incidence of radiation induced sarcoma attributable to radiotherapy in adults: A retrospective cohort study in the SEER cancer registries across 17 primary tumor sites Anson Snow, Alexander Ring, Lucas Struycken, Wendy Mack, Melissa Koç, Julie E. Lang Cancer Epidemiology.2021; 70: 101857. CrossRef
Radiation-Induced Sarcoma: A Retrospective Population-Based Study Over 34 Years in a Single Institution L.B. Callesen, A. Safwat, H.K. Rose, F.B. Sørensen, T. Baad-Hansen, N. Aggerholm-Pedersen Clinical Oncology.2021; 33(5): e232. CrossRef
Proliferating trichilemmal tumour of the eyelid in a 7-year-old girl Avery Bryan, Susan Kurian, Yan Li, Paige Bundrick BMJ Case Reports.2021; 14(2): e237476. CrossRef
Treating radiation-induced sarcoma of the head and neck: A case report Yuka Takumi, Kazufumi Obata, Atsushi Kondo, Ryo Miyata, Ayaka Sasaki, Kenichi Takano Otolaryngology Case Reports.2021; 19: 100283. CrossRef
Pelvic Radiation-Induced Sarcoma With Rhabdomyoblastic Differentiation Following Treatment of Cervical Cancer Shahd S Almohsen, Hala Alnuaim, Alaa A Salim, Haitham Arabi Cureus.2021;[Epub] CrossRef
MYC expression has limited utility in the distinction of undifferentiated radiation‐associated sarcomas from sporadic sarcomas and sarcomatoid carcinoma Jeffrey K Mito, Xiaohua Qian, Vickie Y Jo, Leona A Doyle Histopathology.2020; 77(4): 667. CrossRef
Sarcomas óseos secundarios J.-C. Mattei, A. Griffin, P. Ferguson, G. Venton, J. Wunder, A. Rochwerger EMC - Aparato Locomotor.2020; 53(4): 1. CrossRef
Sarcomes osseux secondaires J.-C. Mattei, A. Griffin, P. Ferguson, G. Venton, J. Wunder, A. Rochwerger EMC - Appareil locomoteur.2020; 34(3): 1. CrossRef
Radiation-Associated Sarcomas Jeffrey K. Mito, Devarati Mitra, Leona A. Doyle Surgical Pathology Clinics.2019; 12(1): 139. CrossRef
A Comparison of Outcomes and Prognostic Features for Radiation-Associated Angiosarcoma of the Breast and Other Radiation-Associated Sarcomas Jeffrey K. Mito, Devarati Mitra, Constance M. Barysauskas, Adrián Mariño-Enriquez, Elizabeth A. Morgan, Christopher D.M. Fletcher, Chandrajit P. Raut, Elizabeth H. Baldini, Leona A. Doyle International Journal of Radiation Oncology*Biology*Physics.2019; 104(2): 425. CrossRef
Osteosarcoma of the jaw – experience at the Medical University Vienna and comparative study with international tumor registries Christina Eder-Czembirek, Doris Moser, Simone Holawe, Thomas Brodowicz, Jutta Ries, Irene Sulzbacher, Edgar Selzer Clinics.2019; 74: e701. CrossRef
Radiation-induced sarcoma in a cat following hypofractionated, palliative intent radiation therapy for large-cell lymphoma Matthew R Cook, Michael P Martinez, Joelle M Fenger, Noopur C Desai Journal of Feline Medicine and Surgery Open Reports.2019;[Epub] CrossRef
Unique Case Report of a Meningeal Sarcoma Arising during Ongoing Treatment for Progressing Intraparenchymal Glioma Richard A. Peterson, Bhavani Kashyap, Pamala A. Pawloski, Anna C. Forsberg, Leah R. Hanson Case Reports in Oncological Medicine.2019; 2019: 1. CrossRef
Radiation‐associated sarcoma after breast cancer in a nationwide population: Increasing risk of angiosarcoma Samuli H. Salminen, Mika M. Sampo, Tom O. Böhling, Laura Tuomikoski, Maija Tarkkanen, Carl P. Blomqvist Cancer Medicine.2018; 7(9): 4825. CrossRef
Radiation-Associated Sarcoma of the Neck: Case Series and Systematic Review Lawrence Williams, Lyubov Tmanova, Wojciech K. Mydlarz, Brandi Page, Jeremy D. Richmon, Harry Quon, Nicole C. Schmitt Annals of Otology, Rhinology & Laryngology.2018; 127(10): 735. CrossRef
Radiation‐associated neoplasia: clinical, pathological and genomic correlates Lynette M Sholl, Justine A Barletta, Jason L Hornick Histopathology.2017; 70(1): 70. CrossRef
Magnetic Resonance Imaging of Soft Tissue Masses Aaron D. Fain, Francesca D. Beaman Seminars in Roentgenology.2017; 52(4): 227. CrossRef
Characteristics of tumors that have developed in mice injected with syngenic irradiated mesenchymal stem cells of bone marrow E. Yu. Moskaleva, E. S. Zhorova, Yu. P. Semochkina, A. V. Rodina, O. V. Vysotskaya, A. I. Glukhov, A. A. Chukalova, G. A. Posypanova, V. P. Saprykin Cell and Tissue Biology.2017; 11(5): 381. CrossRef
Case Report: Primary De Novo Sarcoma In Transplant Pancreas Allograft S. Nagaraju, S.J. Grethlein, S. Vaishnav, A.A. Sharfuddin, J.A. Powelson, J.A. Fridell Transplantation Proceedings.2017; 49(10): 2352. CrossRef
Radiation-induced osteosarcoma of the maxilla and mandible after radiotherapy for nasopharyngeal carcinoma Lie-Qiang Liao, Hong-Hong Yan, Jun-Hao Mai, Wei-Wei Liu, Hao Li, Zhu-Ming Guo, Zong-Yuan Zeng, Xue-Kui Liu Chinese Journal of Cancer.2016;[Epub] CrossRef
Erdheim-Chester disease is a rare non-Langerhans-cell histiocytosis involving bones and multiple organs. Its clinical course can vary, from an asymptomatic state to a fatal disease, with renal involvement being a common cause of death. A 41-year-old man presented with a 10-month history of bilateral lower limb pain. Left perirenal soft-tissue infiltration had been found incidentally two years earlier. No progression of the lesion or deterioration of renal function was observed for a period of two years. At admission, plain radiography and magnetic resonance imaging of the patient's lower limbs showed patchy osteosclerosis.
Biopsy of the tibia revealed histiocytic infiltration, which was found to be positive for CD68 and negative for CD1a.
This report describes an unusual case of Erdheim-Chester disease involving a stationary course of disease with no specific treatment for a long period of time.
Citations
Citations to this article as recorded by
Radiological assessment of extremity bone involvement in Erdheim-Chester disease: a systematic review of case reports Arash Azhideh, Alireza Pouramini, Sara Haseli, Elahe Abbaspour, Gita Karande, Fatemeh Kafi, Majid Chalian Skeletal Radiology.2025; 54(7): 1441. CrossRef
Erdheim–Chester Disease Involving the Biliary System and Mimicking Immunoglobulin G4-Related Disease: A Case Report Hyuk Gi Hong, Yong Eun Chung, June Park, Yeo Eun Kim Journal of the Korean Society of Radiology.2023; 84(3): 757. CrossRef
The role of nuclear medicine in the diagnosis of Erdheim–chester disease. A series of clinical observations A. S. Krylov, A. D. Ryzhkov, A. A. Odzharova, Ya. A. Shchipakhina, E. E. Stanyakina, A. A. Martinovich, K. D. Ilkaev, A. M. Stroganova, S. L. Dranko, O. P. Bliznyukovv, A. V. Kuzin, P. A. Zeynalova, A. A. Semenova, M. B. Dolgushin Oncohematology.2020; 15(1): 28. CrossRef
Erdheim–Chester disease. Literature review and clinical case A. S. Krylov, M. B. Dolgushin, A. D. Ryzhkov, A. A. Odzharova, Ya. A. Shchipakhina, E. A. Sushentsov, O. P. Bliznyukov, S. M. Kaspshik, A. A. Martinovich, A. M. Stroganova, S. L. Dranko, P. A. Zeynalova, T. T. Valiev Oncohematology.2020; 15(2): 61. CrossRef
Magnetic Resonance Imaging of Perirenal Pathology James F. Glockner, Christine U. Lee Canadian Association of Radiologists Journal.2016; 67(2): 149. CrossRef
Erdheim-Chester Disease with Perirenal Masses Containing Macroscopic Fat Tissue Jonghyun Byeon, Kyung Ah Kim, Seong Su Hwang, Soo Youn Park, Hyun A Kim Journal of the Korean Society of Radiology.2015; 72(2): 143. CrossRef
Urologic Manifestations of Erdheim-Chester Disease Daniel A. Yelfimov, Deborah J. Lightner, Matthew K. Tollefson Urology.2014; 84(1): 218. CrossRef
Clinical considerations and key issues in the management of patients with Erdheim-Chester Disease: a seven case series Roei D Mazor, Mirra Manevich-Mazor, Anat Kesler, Orna Aizenstein, Iris Eshed, Ronald Jaffe, Yakov Pessach, Ilan Goldberg, Eli Sprecher, Iris Yaish, Alexander Gural, Chezi Ganzel, Yehuda Shoenfeld BMC Medicine.2014;[Epub] CrossRef
A Rare Cause of Late-Onset Cerebellar Ataxia: Erdheim–Chester Disease Senthilkumar V. Shanmugam, Madhan Kolappan, Mamta Garg, Winston J. Rennie, Peter Furness, Yusuf A. Rajabally The Cerebellum.2013; 12(4): 593. CrossRef
Reply to Commentary on "A Case of Erdheim-Chester Disease with Asymptomatic Renal Involvement" Hyun Jung Lee, Tae Min Kim Cancer Research and Treatment.2012; 44(4): 280. CrossRef
Commentary on "A Case of Erdheim-Chester Disease with Asymptomatic Renal Involvement" Gioacchino Li Cavoli Cancer Research and Treatment.2012; 44(4): 279. CrossRef